MedPath

Low Salt Diet in Idiopathic Hypercalciuria

Phase 2
Completed
Conditions
Hypercalciuria
Interventions
Behavioral: Water therapy alone
Behavioral: Low salt diet
Registration Number
NCT01005082
Lead Sponsor
University of Parma
Brief Summary

Randomized clinical trial comparing water therapy plus low-salt diet to water therapy alone in patients affected by idiopathic calcium nephrolithiasis.

Treatment duration: three months Primary end-point: correction of hypercalciuria Main inclusion criteria: calcium stone formers with idiopathic hypercalciuria, with at least one stone expelled and analyzed by infrared spectrophotometry; presence of hypercalciuria (\>300 mg/day in males and \>200 mg/day in females); 18-65 years.

Main exclusion criteria: primary hyperparathyroidism, primary hyperoxaluria, enteric hyperoxaluria, bowel resection, inflammatory bowel disease, renal tubular acidosis, sarcoidosis, sponge kidney, hyperthyroidism, use of hypercalciuric drugs such as Vitamin D, acetazolamide, anti-epileptic drugs

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
210
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
water therapy aloneWater therapy alone-
Low salt diet plus water therapyLow salt diet-
Primary Outcome Measures
NameTimeMethod
Normalization of urinary calcium levels
Secondary Outcome Measures
NameTimeMethod
Change in urinary stone risk factors (e.g. urinary calcium, oxalate and sodium excretion); blood pressure reduction

Trial Locations

Locations (1)

University Hospital

🇮🇹

Parma, Italy

© Copyright 2025. All Rights Reserved by MedPath